Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (201-210 of 1,622) with videos related to

Pageof 163
Sort By:
Case Reports in Oncology|August 27, 2010
Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?Maurie Markman
Case Reports in Oncology|August 27, 2010
Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case ReportMaurie Markman
Clinical Advances in Hematology & Oncology : H&O|June 24, 2008
Second-line therapy for ovarian cancerMaurie Markman
Anesthesia Progress|July 15, 2009
Letter to the editorS Markman
The Journal of the American College of Dentists|April 27, 2010
Academic integrity in dental school: a call to actionStanley Markman
Gynecologic Oncology|April 28, 2010
Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: time for an evidence-based comparisonMaurie Markman
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Point: Intraperitoneal chemotherapy in the management of ovarian cancerMaurie Markman
Gynecologic Oncology|April 13, 2007
A relevant historical perspective on the current toxicity of IP chemotherapy: implications for the futureMaurie Markman
Oncology|September 18, 2007
Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based dataMaurie Markman
Oncology|February 28, 2009
Hypersensitivity reactions: an increasingly recognized toxicity of platinum agentsMaurie Markman
Pageof 163

Showing results (201-210 of 1,622) with videos related to

Sort By:
Pageof 163
Case Reports in Oncology|August 27, 2010
Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?Maurie Markman
Case Reports in Oncology|August 27, 2010
Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case ReportMaurie Markman
Clinical Advances in Hematology & Oncology : H&O|June 24, 2008
Second-line therapy for ovarian cancerMaurie Markman
Anesthesia Progress|July 15, 2009
Letter to the editorS Markman
The Journal of the American College of Dentists|April 27, 2010
Academic integrity in dental school: a call to actionStanley Markman
Gynecologic Oncology|April 28, 2010
Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: time for an evidence-based comparisonMaurie Markman
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Point: Intraperitoneal chemotherapy in the management of ovarian cancerMaurie Markman
Gynecologic Oncology|April 13, 2007
A relevant historical perspective on the current toxicity of IP chemotherapy: implications for the futureMaurie Markman
Oncology|September 18, 2007
Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based dataMaurie Markman
Oncology|February 28, 2009
Hypersensitivity reactions: an increasingly recognized toxicity of platinum agentsMaurie Markman
Pageof 163